Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.

Biotechnology

Tessera Therapeutics

Michael Severino

David Tefft

Joel Nichols

Cecilia Cotta-Ramusino

Yohann Potier

Jody Massey

Cynthia Patton

Anne-Virginie Eggimann

Hari Pujar

Howard Liang

David Davidson

Becky Lillie

Michael Holmes

Vikram Ranade

Jacob Rubens

The Scientific Research Team at Tessera Therapeutics is responsible for pioneering and advancing the company's Gene Writing technology. This team, composed of experts across various scientific disciplines, engages in cutting-edge research to develop therapies that can edit the human genome, aiming to cure diseases at their source. Their work involves molecular assays, computational biology, immune oncology process sciences, and analytical development, collaborating to transform innovative scientific concepts into therapeutic realities.

Scientific Research Team

Directors & Managers

Engineering and Data Science

Scientific Research Team

About

Team members

Other teams at Tessera Therapeutics

Directors & Managers

Engineering and Data Science